Scinai Immunotherapeutics (SCNI) Other financing activities (2020 - 2024)

Scinai Immunotherapeutics has disclosed Other financing activities across 4 years of filings, most recently posting $8000.0 for Q3 2024.

• In Q3 2024, Other financing activities rose 300.0% year-over-year to $8000.0; the TTM figure through Dec 2024 stood at $1.4 million (up 52.16% YoY), while the FY2025 annual figure was $150000.0, down 89.59% from the prior year.
• Other financing activities came in at $8000.0 for Q3 2024 at Scinai Immunotherapeutics, down from $12000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $10.3 million in Q2 2020 to a low of -$4000.0 in Q3 2023.
• Average Other financing activities over 4 years is $1.9 million, with a median of $146500.0 recorded in 2020.
• Year-over-year, Other financing activities sank 85.54% in 2023 and soared 1300.0% in 2024.
• Over 4 years, Other financing activities stood at $166000.0 in 2020, then surged by 3337.95% to $5.7 million in 2022, then slumped by 85.54% to $825000.0 in 2023, then plunged by 99.03% to $8000.0 in 2024.
• Per Business Quant data, the three most recent Other financing activities figures were $8000.0 in Q3 2024, $12000.0 in Q2 2024, and $1.4 million in Q1 2024.